A growth-factor cocktail containing NMN in hair-loss research

A multi-component intervention for androgenetic alopecia

The research discussed in this archive concerns a growth-factor cocktail containing FGF5s and NMN, delivered with a microneedling procedure. It does not investigate NMN as an oral supplement on its own.

Androgenetic alopecia can affect both men and women. The original article places the experimental intervention alongside established medical and surgical approaches, but that context does not make their evidence or suitability equivalent.

Why growth factors were investigated

Researchers have investigated signaling molecules involved in the hair-growth cycle and the behavior of hair follicles. FGF5s, the short form of fibroblast growth factor 5, was discussed in relation to the transition between growth-cycle phases.

The archive also mentions earlier work involving other growth factors. Results from a different formulation should not be attributed automatically to the FGF5s-and-NMN preparation or to NMN alone.

How the experimental preparation was delivered

The intervention involved microneedling to facilitate delivery through the skin. The original article describes a depth of approximately 0.8 mm as part of the study method.

This detail explains the experimental procedure; it is not guidance for carrying out treatment at home. Microneedling itself can affect tissue responses, making it especially important to distinguish the contribution of the procedure from that of each ingredient.

What the NMN component means

NMN is a precursor involved in NAD+ biosynthesis and cellular metabolism. Including it in a multi-ingredient preparation does not establish that NMN alone accounts for any observed response.

The archive does not provide enough numerical outcome data, participant details or adverse-event information to evaluate the size and reliability of a clinical effect from this entry alone. A complete assessment would require the primary paper.

What cannot be concluded

This discussion does not establish that drinking an NMN supplement promotes hair growth, treats androgenetic alopecia or replaces prescribed medication. It also does not establish the effects of a GAAH product.

Cited paper: Therapeutic effects of growth factor cocktail (Cellcurin™) containing FGF5s and NMN in patients with androgenetic alopecia: A split study. The English edition distinguishes the cocktail, the delivery procedure and NMN as an individual ingredient.